Tonix Pharmaceuticals
TNXP
19 hedge funds and large institutions have $5.81M invested in Tonix Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
189% more capital invested
Capital invested by funds: $2.01M → $5.81M (+$3.8M)
36% more funds holding
Funds holding: 14 → 19 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.36M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$1.21M |
| 3 |
AC
Armistice Capital
New York
|
+$1.17M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$929K |
| 5 |
ACM
Altium Capital Management
New York
|
+$272K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$37K |
| 2 |
JP Morgan Chase
New York
|
-$11.3K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$9.66K |
| 4 |
BlackRock
New York
|
-$3.22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GPFA
26
Game Plan Financial Advisors
Westlake,
Ohio
| $15 | – | – | – |
|
|
AWM
27
Able Wealth Management
Toms River,
New Jersey
| $12 | – | – | – |
|
|
FDCDDQ
28
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $11 | – | – | – |
|
29
Fidelity Investments
Boston,
Massachusetts
| $10 | – | – | – |
|
|
BHWM
30
Beaird Harris Wealth Management
Dallas,
Texas
| $6 | – | – | – |
|
|
GI
31
Gradient Investments
Arden Hills,
Minnesota
| $4 | – | – | – |
|
|
NSIM
32
North Star Investment Management
Chicago,
Illinois
| $3 | – | – | – |
|
33
Qube Research & Technologies (QRT)
London,
United Kingdom
| $2 | – | – | – |
|
|
GWSA
34
Global Wealth Strategies & Associates
Denver,
Colorado
| $1 | – | – | – |
|
|
IA
35
IFP Advisors
Tampa,
Florida
| $1 | – | – | – |
|
|
PA
36
Parallel Advisors
San Francisco,
California
| $1 | – | – | – |
|
|
TCM
37
Tradewinds Capital Management
Bellingham,
Washington
| $1 | – | – | – |
|
|
VF
38
Virtu Financial
New York
| – | -$37K | -21 | Closed |
|
|
39
JP Morgan Chase
New York
| – | -$11.3K | -6 | Closed |
|
TNXP Hedge Fund Activity: Q4 2023 in Review
19 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q4 2023, worth a combined $5.81M — up 189% from $2.01M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new TNXP positions and 2 closed out — a net gain of 5 holders — while 7 added to existing stakes and 2 trimmed.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $1.36M. The largest seller was Virtu Financial, exiting entirely with an estimated $37K sold.
- 19 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q4 2023, up from 14 in Q3 2023.
- Funds reported $5.81M of Tonix Pharmaceuticals stock for Q4 2023, up 189% quarter-over-quarter.
- 7 funds opened new Tonix Pharmaceuticals positions in Q4 2023 and 2 closed out, a net change of +5 holders.
- The largest Tonix Pharmaceuticals buyer in Q4 2023 was Alyeska Investment Group, an estimated $1.36M added.
- The largest Tonix Pharmaceuticals seller in Q4 2023 was Virtu Financial, an estimated $37K sold.
Based on aggregated 13F filings for Q4 2023.